{"id":962749,"date":"2026-05-14T08:47:27","date_gmt":"2026-05-14T12:47:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/"},"modified":"2026-05-14T08:47:27","modified_gmt":"2026-05-14T12:47:27","slug":"agomab-to-participate-in-upcoming-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/","title":{"rendered":"Agomab to Participate in Upcoming Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <b>Antwerp, Belgium, May 14, 2026<\/b> \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-J7FIPX4kxbo7YNJiSbHmAS9RDFf8YL4Bkkizc8Z1Ub7r3GS2APpRrlV_HGsJ5Noq4e8fiA3JUpWR1S9sMcSJgMxPgMDtSPe0oSpLWeHShE=\" rel=\"nofollow\" target=\"_blank\">Agomab Therapeutics NV<\/a> (Nasdaq: AGMB) (\u201cAgomab\u201d), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming industry and investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <b>ATS International Conference 2026. <\/b>Poster Board #904 titled <i>\u2018AGMB-447, an Inhaled Lung-Restricted TGF\u03b2R1\/ALK5 Inhibitor Intended for the Treatment of Idiopathic Pulmonary Fibrosis, Shows Robust Anti-Fibrotic Activity and Target Engagement in Preclinical Species and Healthy Subjects\u2019 <\/i>on Wednesday, May 20, 2026 at 8:15 AM ET in Orlando, FL. <\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <b>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ. <\/b>Fireside chat on Tuesday, May 19, 2026 at 1:30 PM ET in New York, NY.<\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <b>2026 RBC Capital Markets Global Healthcare Conference. <\/b>Fireside chat on Wednesday, May 20, 2026 at 8:00 AM ET in New York, NY. <\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <b>JPM European Healthcare Symposium. <\/b>Wednesday, June 10, 2026 in London, UK.<\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <b>BIO International Convention.<\/b> Monday, June 22 &#8211; Thursday, June 25, 2026 in San Diego, CA. <\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <b>2026 Leerink Partners Therapeutics Forum.<\/b> One-on-one investor meetings on Wednesday, July 15, 2026 in Boston, MA.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <b>About Agomab<\/b><br \/>\n        <br \/>Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for fibro-inflammatory diseases with high unmet medical need.\u00a0Agomab\u2019s\u00a0product candidates are designed to target established potent pathways and\u00a0utilize\u00a0organ-restricted approaches, with the aim of increasing efficacy while minimizing safety liabilities.\u00a0Fostering a culture of excellence, Agomab\u2019s\u00a0mission is to pioneer therapeutics that aim to resolve fibro-inflammation and restore organ function to enable people with these disorders to live fuller and healthier lives.<\/p>\n<p align=\"justify\">\n        <b>Contacts<\/b><br \/>\n        <br \/>\n        <b>Investors<\/b><br \/>\n        <br \/>Sofie Van Gijsel<br \/>VP of Investor Relations<br \/>E-Mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JX_yoisK0wBDqUaxoOVZUWcSXSL19PNbgu80ElDD1ypY1B3HM8SB9UeAzkZ3JUNfM49VsMOWhw5QVjjZ5dH-JzQzMPQZRf3pyuNLwB_Wx47vujHb2o8Wl4CBkf5WgPBr\" rel=\"nofollow\" target=\"_blank\">sofie.vangijsel@agomab.com<\/a><br \/>Phone: +1 781 296 1143<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><b>Media<\/b><br \/>Gretchen Schweitzer<br \/>Trophic Communications<br \/>E-Mail: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GVYF91uByu0InFjc-DGsbmR4s91o1ogkEHTtcWje4L8f-p3ODZ3wf8NC_Toxh8veuhh2fNkrho2DzRIOCtAXxj1G5cyztp0IhwUDlFLcqUM=\" rel=\"nofollow\" target=\"_blank\">agomab@trophic.eu<\/a>\u00a0<br \/>Phone: +49 172 861 8540<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NGZjMzMxNzUtMGIzMi00YTFmLWExZWMtODdlNzNhZjE1YzA3LTEzMTE5MTktMjAyNi0wNS0xNC1lbg==\/tiny\/AgomAb-Therapeutics-NV.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Antwerp, Belgium, May 14, 2026 \u2013 Agomab Therapeutics NV (Nasdaq: AGMB) (\u201cAgomab\u201d), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming industry and investor conferences: ATS International Conference 2026. Poster Board #904 titled \u2018AGMB-447, an Inhaled Lung-Restricted TGF\u03b2R1\/ALK5 Inhibitor Intended for the Treatment of Idiopathic Pulmonary Fibrosis, Shows Robust Anti-Fibrotic Activity and Target Engagement in Preclinical Species and Healthy Subjects\u2019 on Wednesday, May 20, 2026 at 8:15 AM ET in Orlando, FL. H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ. Fireside chat on Tuesday, May 19, 2026 at 1:30 PM ET in New York, NY. 2026 RBC Capital Markets Global Healthcare Conference. Fireside chat on Wednesday, May &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agomab to Participate in Upcoming Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-962749","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agomab to Participate in Upcoming Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agomab to Participate in Upcoming Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Antwerp, Belgium, May 14, 2026 \u2013 Agomab Therapeutics NV (Nasdaq: AGMB) (\u201cAgomab\u201d), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming industry and investor conferences: ATS International Conference 2026. Poster Board #904 titled \u2018AGMB-447, an Inhaled Lung-Restricted TGF\u03b2R1\/ALK5 Inhibitor Intended for the Treatment of Idiopathic Pulmonary Fibrosis, Shows Robust Anti-Fibrotic Activity and Target Engagement in Preclinical Species and Healthy Subjects\u2019 on Wednesday, May 20, 2026 at 8:15 AM ET in Orlando, FL. H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ. Fireside chat on Tuesday, May 19, 2026 at 1:30 PM ET in New York, NY. 2026 RBC Capital Markets Global Healthcare Conference. Fireside chat on Wednesday, May &hellip; Continue reading &quot;Agomab to Participate in Upcoming Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-14T12:47:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agomab to Participate in Upcoming Conferences\",\"datePublished\":\"2026-05-14T12:47:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/\"},\"wordCount\":259,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/\",\"name\":\"Agomab to Participate in Upcoming Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\",\"datePublished\":\"2026-05-14T12:47:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agomab-to-participate-in-upcoming-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agomab to Participate in Upcoming Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agomab to Participate in Upcoming Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Agomab to Participate in Upcoming Conferences - Market Newsdesk","og_description":"Antwerp, Belgium, May 14, 2026 \u2013 Agomab Therapeutics NV (Nasdaq: AGMB) (\u201cAgomab\u201d), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming industry and investor conferences: ATS International Conference 2026. Poster Board #904 titled \u2018AGMB-447, an Inhaled Lung-Restricted TGF\u03b2R1\/ALK5 Inhibitor Intended for the Treatment of Idiopathic Pulmonary Fibrosis, Shows Robust Anti-Fibrotic Activity and Target Engagement in Preclinical Species and Healthy Subjects\u2019 on Wednesday, May 20, 2026 at 8:15 AM ET in Orlando, FL. H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ. Fireside chat on Tuesday, May 19, 2026 at 1:30 PM ET in New York, NY. 2026 RBC Capital Markets Global Healthcare Conference. Fireside chat on Wednesday, May &hellip; Continue reading \"Agomab to Participate in Upcoming Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-14T12:47:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agomab to Participate in Upcoming Conferences","datePublished":"2026-05-14T12:47:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/"},"wordCount":259,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/","name":"Agomab to Participate in Upcoming Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==","datePublished":"2026-05-14T12:47:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTE4MTkyOSM0MDIzOTIyMzMjMjMwMDM2OQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agomab-to-participate-in-upcoming-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agomab to Participate in Upcoming Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=962749"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962749\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=962749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=962749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=962749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}